Certain identified information has been excluded from the exhibit because it is both (i) not material and (ii) would likely cause competitive harm to the Company, if publicly disclosed. Double asterisks denote omissions. Royalty Purchase Agreement by...Royalty Purchase Agreement • July 30th, 2020 • Agios Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
